Skip to main content
. 2016 Mar 2;14(3):e1002376. doi: 10.1371/journal.pbio.1002376

Fig 1. Portfolio analysis for global health impact.

Fig 1

Cost per disability-adjusted life year (DALY) averted is the incremental cost to deliver incremental DALY savings versus only the standard of care. Probability of success is the estimate of probability of technical and regulatory success (PTRS) informed by industry benchmarks and expert opinion. NRRV: Non-replicating rotavirus vaccine. Both the cost and the probability of success are dynamic values and subject to change with information that is constantly evolving.